Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

Peder af Geijerstam, Michael O. Falster, John Chalmers, Andrew J. McLachlan, Anthony Rodgers, Aletta E. Schutte

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
17 Downloads (Pure)

Abstract

The duration of treatment for which a physician may prescribe a medicine, ‘prescription duration’, is often dispensed at the pharmacy on multiple occasions of shorter time periods, ‘dispensing duration’. These durations vary significantly between and within countries. In Australia, the quantity of medication supplied at each dispensing has recently been extended from 30 to 60 days for a selection of medicines used for chronic health conditions, such as diabetes and hypertension. Dispensing durations vary between countries, with 30, 60 or 90 days being the most common—with 90 days aligning with the recommendation of the 2023 Global Report on Hypertension from the World Health Organization. The full impact of shorter vs longer prescription durations on health costs and outcomes is unknown, but current evidence suggests that 90-day dispensing could reduce costs and improve patient convenience and adherence. More rigorous research is needed. (Figure presented.)

Original languageEnglish
Pages (from-to)2104-2114
Number of pages11
JournalHYPERTENSION RESEARCH
Volume47
Issue number8
DOIs
Publication statusPublished - Aug 2024
Externally publishedYes

Keywords

  • Dispensing duration
  • Health costs
  • Health outcomes
  • Medication adherence
  • Prescription duration

Cite this